Pathological and ultra-structural biocompatibility of polypropylene mesh in a non-infected rabbit mo

来源 :第八届全国创伤修复(愈合)与组织再生学术交流会 | 被引量 : 0次 | 上传用户:lbtx368
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective to evaluate the biocompatibility and shrinkage ofpolypropylene mesh implanted in a non-infected rabbit model after 30 days,90 days and 180 days,respectively.Method 10 pieces of polypropylene meshes sized 10mm×40mm were implanted on subcutaneous tissue of 6 New Zealand white rabbits respectively.Mesh-tissues and subcutaneous tissue-muscle were explanted after 30 days,90 days and 180 days (2 rabbits per group).Shrinkage of all samples were recorded and all samples were evaluated for inflammatory response and fiber capsule formation by light microscopy.Each of these two categories was graded on a scale of Ⅰ-Ⅳ according to GB/T16886.6-1997.All samples were also evaluated for integration by scanning electron microscope.All measurement data were analyzed using Analysis of Variance with P<0.05 as significant.Results There were no signs of infection,erosion and exposure observed on the surgical site in all the rabbits.Shrinkage of the meshes in group A,group B and group C was 4.5%±1.4%,5.0%±2.0%,6.7%±2.2%,respectively.The mesh shrank to a greater extent with time,while group C shrank greatest,with significant difference comparing to group A and B.There was no statistically significant difference between group A and B.Pathological study showed that both inflammation and fiber capsule formation were class Ⅱ in group A and < class Ⅰ in Group B,Group C and Group D.There were no obvious esophylic and atrophic changes in the muscular tissue in all the groups.Ultra-structural study showed that connective tissue was well integrated into the mesh and fiber capsule was becoming thinner with time.No fracture occurred in the mesh fiber.Conclusion Polypropylene mesh shrank to a greater extent with time and presented excellent biocompatibility in the rabbit model.
其他文献
目的:总结了11例特殊部位慢性创面(如臀部压疮、骶尾部压疮、会阴部溃疡)且进行手术患者的护理经验。方法:对11例特殊部位慢性创面且进行手术的患者,术前运用TIME原则指导护士进行创面护理,术后注重体位护理和伤口护理。结果:本组11例患者创面8例Ⅰ期愈合,3例Ⅱ期愈合。出院后追踪随访3~20个月,无一复发。结论:TIME原则可作为术前创面床准备指导工具,结合术后体位护理和伤口护理,将慢性创面护理规范
会议
目的:探讨下肢动脉性慢性创面介入治疗后无再流现象的预防与治疗。方法:笔者所在科室2009-2012年收治下肢动脉闭塞缺血所致足部慢性创面患者30例,其中20例患者行下肢动脉闭塞狭窄部位球囊扩张、支架植入治疗后,行小腿或足部带蒂皮瓣转移修复创面。结果:介入治疗后全部患者肢端缺血表现均有改善,皮温增高、颜色较前红润。其中2例患者介入治疗后短期效果明显,但2-3天后出现皮温降低,皮瓣创缘皮肤坏死表现。结
会议
目的:探讨碱性成纤维细胞生长因子(bFGF)对人脐带间充质干细胞(HUCMSCs)增殖及Ⅰ、Ⅲ型胶原产生的影响.方法:贴壁培养HUCMSCs,分为实验组和对照组,实验组添加bFGF (2μg·L-1)于L2DMED培养液中,对照组使用L2DMED常规培养液.分别测定2组HUCMSCs生长曲线,MTT法分析bFGF对HUCMSCs增殖的影响,流式细胞仪分析其表面HUCMSCs标记(CD45、CD34
目的:观察阻断血管紧张素Ⅱ (angiotensin Ⅱ,Ang Ⅱ)1型受体(type 1 receptor,AT1R)对创面愈合过程的上皮爬行、肉芽组织形成以及创伤局部生长因子产生的影响,探讨Ang Ⅱ及AT1R影响创伤愈合的分子机制.方法:建立小鼠背部全层皮肤缺损创面模型,直径6mm,在创面模型建立同时腹腔给予AT1R阻断剂Losartan(每天20mg/kg),在创面形成后第3、5、7、9
会议
会议
创面修复是一个复杂而有序的生物学过程,多种细胞成份如巨噬细胞、中性粒细胞、成纤维细胞、角质形成细胞、血管内皮细胞等修复细胞,以及细胞因子和生长因子,细胞外基质成份等参与创面的修复过程。随着对创面愈合的细胞和分子机制以及成体干细胞在各种组织、器官修复与再生过程中作用研究的不断深入,人们发现在损伤后机体除动员创伤局部组织的细胞直接参与修复以恢复受损组织的完整性外,还通过动员不同来源的干细胞通过向受损组
目的:探讨自体脂肪颗粒组织移植预防瘢痕与深部组织粘连松解术后再发生粘连的方法和材料。方法:2010年8月-2011年4月期间,我们对符合条件的15例皮肤外伤或手术后瘢痕与深部肌肉和腱性组织粘连的病例采用原瘢痕处小切口,仔细分离松解皮下粘连组织,并在粘连处形成皮下袋,将下腹部经20ml注射器抽吸得到的脂肪颗粒用2mm内径注射针注入到分离的皮下袋内,移植的自体脂肪颗粒作为隔离层填充于原粘连组织间,缝合
目的 探讨17β-雌二醇(17β-E2)对骨髓间充质干细胞(bone marrow mesenchymal stem cells,BMSCs)增殖、成肌分化的影响,以提高BMSCs成骨骼肌分化效率,为压力性尿失禁(stress urinary incontinence,SUI)的注射疗法提供足量细胞,同时在细胞水平上探索雌激素治疗SUI的作用机理,为临床用药提供理论依据.方法 利用贴壁法体外分离、
目的:介绍一种新型全阴道修复网片(total vaginal mesh,TVM)Prolift系统在盆腔器官脱垂手术中的应用。方法:选择Ⅱ度以上子宫或/和阴道壁脱垂患者15例:其中本次手术前已经切除子宫者5例,术中同时切除子宫者5例,保留子宫者5例;9例使用全盆底修复网片(total Prolift),6例使用前部修复网片(anterior Prolifi);有5例患者因合并压力性尿失禁同时行TV